| Literature DB >> 35399635 |
Yang Fu1, Dan-Ni Ding2, Ying Shen1, Li-Yan Jia1, Meng-Yu Yan2, Wei Wei2, Chang-Hong Song1, Feng-Juan Han1.
Abstract
Premature ovarian insufficiency (POI) is defined as a decline in ovarian function before the age of 40 and is one of the leading causes of infertility in women. The etiology is complex, and the pathogenesis is not clear. The main treatment is hormone replacement therapy, but a growing body of data confirms that such treatment can increase the risk of endometrial disease and cardiovascular disease. Complementary and alternative medicine (CAM) has been widely used in patients with POI due to its limited adverse reactions and high efficiency. According to literature reports, CAM therapy for POI mainly includes traditional Chinese medicine, acupuncture, psychotherapy, dietary supplements, and exercise therapy. This article reviews the application of CAM in the treatment of POI and attempts to determine the therapeutic effects and the mechanisms behind these effects based on existing clinical and experimental studies in order to provide theoretical support for the treatment of POI.Entities:
Year: 2022 PMID: 35399635 PMCID: PMC8993576 DOI: 10.1155/2022/9053930
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Etiologies of POI.
General view of all therapeutic approaches.
| Therapeutic approaches | Specifications | Efficacy | Precautions | Refs. |
|---|---|---|---|---|
| Herbal products | Appropriate TCM prescriptions are proposed according to TCM doctors' judgment. | Improves hormone levels and relieves clinical symptoms in patients with POI. | Allergies to drugs or contraindications. | [ |
|
| ||||
| Acupuncture and moxibustion | The appropriate acupoints or moxa-moxibustion therapy are chosen based on the disease status of the patient. A typical course of acupuncture is about 30 min, a course of electroacupuncture is about 5–20 min, and a course of treatment with moxibustion is about 40–50 min. | Improves hormone levels and relieves clinical symptoms in patients with POI. | Be careful of fainting conditions. | [ |
|
| ||||
| Psychotherapy | Physicians train, educate, and treat patients to reduce or eliminate their physical symptoms, either verbally or nonverbally. | Relieves clinical symptoms and improves hormone levels in patients with POI. | Be alert for the development of psychological resistance. | [ |
|
| ||||
| Dietary supplements | Different dietary interventions are used to regulate bodily functions and promote health. | Improves hormone levels and relieves clinical symptoms in patients with POI. | Adherence to use should be monitored, but this is not to be an alternative to the usual diet. | [ |
|
| ||||
| Exercise therapy | Planned, structured, and repetitive limb activities are used to improve physical health as well as mental health. | Relieves clinical symptoms in patients with POI. | Avoid excessive muscle fatigue. | [ |
Herbal mixtures for POI treatment in the literature.
| Herbal mixture; number of patients ( | Ingredients | Control treatment; number of patients ( | Total clinical effect rate | Model used | Therapeutic effects and actions | Refs. |
|---|---|---|---|---|---|---|
| Bushen Culuan decoction (BCD); | Tu Si Zi, Yin Yang Huo, Xian Mao, Xu Duan, Gou Qi Zi, Nv Zhen Zi, Ze Lan, Pu Huang, Xiang Fu, Chuan Shan Long | E2 valerate, clomiphene, and progesterone; | T: 95.35% vs. 88.37%; O: 59.69% vs. 71.32%; P: 27.91% vs. 23.26% | Human study | FSH↓ LH↓ E2↑ AMH↑ AFC↑ reduced TCM syndrome scores | [ |
| Bushen Huoxue Decoction (BHD); | Shu Di Huang, Shan Yao, Shan Yu Rou, Tu Si Zi, Gou Qi Zi, Dang Gui, Bai Shao, Chuan Xiong, Dan Shen, Xiang Fu, Chuan Niu Xi, Gan Cao | HRT; | T: 100% vs. 70% | Human study | FSH↓ LH↓ E2↑ FSH/LH↓ reduced TCM syndrome scores | [ |
| Huyang Yangkun Recipe (HYR); | Huang Qi, Dang Gui, Shan Yao, Shu Di Huang, Xian Ling Pi, Tu Si Zi, Sha Shen | Dehydroepi androsterone; | T: 94.55% vs. 85.45% | Human study | Promoted menstruation recovery. FSH↓ E2↑ AMH↑ | [ |
| Erxian Decoction (EXD); | Ba Ji Tian, Xian Mao, Dang Gui, Lu Jiao Shuang, Mu Dan Pi, Zhi Mu, Niu Xi, Huang Bai, Gan Cao, Yin Yang Huo, Chuan Xiong, Shu Di Huang, Nv Zhen Zi, Yi Mu Cao | HRT; | T:95.00% vs. 77.50% | Human study | FSH↓ LH↓ E2↑ reduced TCM syndrome scores increased quality of life scores | [ |
| Huluan Decoction (HLD); | Du Zhong, Tu Si Zi, Fu Pen Zi, Gou Qi Zi, Dang Shen, Huang Qi, Huang Jing, Bai Zhu, Ju Ye, San Qi Hua, Shi Hu, Yu Zhu, Bai He, Shan Yao, Lian Zi, Hei Dou, Ge Gen, Zi He Che, E Jiao, Gan Cao | Femoston; | T: 83.3% vs. 66.7% | Human study | FSH↓ LH↓ E2↓ FSH/LH↓ AFC↑ ovarian volume↑ reduced TCM syndrome scores | [ |
Note. T (total effect rate) = number of effective cases/total number of cases, where effective case refers to the patients or animal models whose signs and symptoms were improved after treatment; O: ovulation rate; P: pregnancy rate; E2: estradiol; FSH: follicle-stimulating hormone; LH: luteinizing hormone; AFC: antral follicle counts; AMH: anti-Müllerian hormone; TCM: traditional Chinese medicine; HRT: hormone replacement therapy.
Chinese traditional patent medicines for treating POI.
| Chinese traditional patent medicine; number of patients ( | Ingredients | Control sample; number of patients ( | Total clinical effect rate | Model used | Therapeutic effects and actions | Refs. |
|---|---|---|---|---|---|---|
| Kuntai Capsules (KTC); | Shu Di Huang, Huang Lian, Bai Shao, Huang Qin, E Jiao, Fu Ling | E2 valerate; | Human study | FSH↓ LH↓ E2↑ TC↓ TG↓ LDL-C↓ HDL-C↑ | [ | |
| Yulin pill (YLP); | Shu Di Huang, Tu Si Zi, Dang Gui, Chuan Xiong, Bai Shao, Ren Shen, Bai Zhu, Fu Ling, Lu Jiao Shuang, Du Zhong, Gan Cao, Chuan Jiao | HRT; | T: 83.3% vs. 70.0% | Human study | FSH↓ LH↓ E2↑ EM↑ AFC↑ Reduced TCM syndrome scores | [ |
| Bushen Yangjing Granules (BYG) | Shu Di Huang, Dang Gui, Bai Shao, Chuan Xiong, Tu Si Zi, Gou Qi Zi, Che Qian Zi, Wu Wei Zi, Fu Pen Zi, Chuan Niu Xi, Xiang Fu, Zhi Qiao, Dang Shen, Yin Yang Huo, Zhi Mu, Yi Mu Cao | Progynova | Sprague–Dawley rat model | NF- | [ | |
| Yangyin Shugan Capsules (YSC); | Chai Hu, Yu Jin, Bai Shao, Shan Yao, Di Huang, Fu Ling, Xiang Fu | Placebo; | T: 93.3% vs. 63.3% | Human study | FSH↓ LH↓ E2↑ reduced TCM syndrome scores | [ |
Note. T (total effect rate) = number of effective cases/total number of cases, where effective case refers to the patients or animal models whose signs and symptoms were improved after treatment; E2: estradiol; FSH: follicle-stimulating hormone; LH: luteinizing hormone; AFC: antral follicle count; TCM: traditional Chinese medicine; HRT: hormone replacement therapy; VEGF: vascular endothelial growth factor; TC: total cholesterol; TG: triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: low-density lipoprotein cholesterol; MMP: matrix metalloproteinase; EM: endometrium.
Acupuncture for POI.
| Treatment; sample number ( | Control; sample number ( | Total clinical effect rate | Model used | Therapeutic effects and actions | Refs. |
|---|---|---|---|---|---|
| Acupuncture; | E2 and dydrogesterone tablets; | T: 93.3% vs. 60.0% | Human study | TCM symptom score↓ FSH↓ LH↓ E2↑ AMH↑ AFC↑ | [ |
| Moxibustion; | Complex packing E2; | T: 87.1% vs. 80.65% | Human study | FSH↓ LH↓ E2↑ | [ |
| Acupoint sticking treatment; | Vitamin E; | T: 94.29% vs. 71.43% | Human study | FSH↓ E2↑ | [ |
| Auricular acupoint treatment; | TCM decoction; | T: 93.75% vs. 81.25% | Human study | TCM symptom score↓ FSH↓ LH↓ E2↑ | [ |
| Acupuncture combined with TCM; | Artificial menstrual cycle; | T: 86.05% vs. 71.95% | Human study | TCM symptom score↓ | [ |
| Acupuncture combined with ginger moxibustion; | Acupuncture combined with uterus-warming moxibustion; | T: 75% vs. 77.78% | Human study | TCM symptom score↓ FSH↓ LH↓ E2↑ | [ |
Note. T (total effect rate) = number of effective cases/total number of cases; effective case refers to the patients or animal models whose signs and symptoms were improved after treatment; E2: estradiol; FSH: follicle-stimulating hormone; LH: luteinizing hormone; AFC: antral follicle count; AMH: anti-Müllerian hormone; TCM: traditional Chinese medicine.
The rules of acupoint selection of acupuncture for POI.
| Meridian | Acupoints | Refs. |
|---|---|---|
| Ren Channel (RN) | Guanyuan (RN 4), Zhongwan (RN 12) | [ |
| Du Channel (DU) | Baihui (DU 20), Shenting (DU 24) | [ |
| Stomach Meridian of Foot Yangming (ST) | Zusanli (ST 36), Tianshu (ST 25), Guilai (ST 29) | [ |
| Shaoyin Kidney Meridian of Foot (KI) | Taixi (KI 3) | [ |
| The Spleen Meridian of Foot Taiyin (SP) | Sanyinjiao (SP 6) | [ |
| Taiyang Bladder Meridian of Foot (BL) | Shenshu (BL 23), Ciliao (BL 32) | [ |